Suggestions
Kaustuva Das
Sales Director - Strategic Sales
Professional Background
Kaustuva Das is a dynamic and accomplished professional with extensive experience across a multitude of sectors including Sales, Consulting, Operations Management, Relationship Management, and Business Development. His career is characterized by a proven track record of defining and implementing innovative business models, organizational restructuring, and optimizing business processes and technology systems. With international experience, Kaustuva has successfully collaborated with various customers spanning multiple industries, making him a versatile asset in any organizational setup.
Kaustuva has impeccable credentials in Sales and Engagement Management. He excels in winning new clients, expanding portfolios with existing clients while managing customer engagements effectively. His adeptness in building partnerships and coordinating delivery has seen him contribute significantly to business transformation agendas for both new and established clients. By integrating Digital, Automation, Analytics, and Enterprise Technology solutions, along with successful outsourcing initiatives, he has consistently delivered enhanced value to clients, reflecting his strategic foresight and operational excellence.
Education and Achievements
Kaustuva Das’s educational background is equally impressive. He studied MBA specializing in Marketing from the prestigious S.P. Jain Institute of Management & Research, honing his skills in marketing strategies that propel business growth and enhance customer engagement. Prior to this, he earned a Bachelor of Engineering in Metallurgy from the National Institute of Technology, Tiruchirappalli. This strong technical foundation complements his business acumen and provides depth to his analytical skills, both of which are crucial in today's data-driven decision-making environment.
Career Progression
Throughout his career, Kaustuva has held several pivotal roles in leading organizations. He was formerly the Sales Director for the Products Operating Group at Accenture, where he was instrumental in driving sales strategies and fostering long-term relationships with clients, thereby contributing to the company's impressive growth trajectory.
His tenure at Cognizant is marked by various key roles including Account Director and Client Sales Executive, where he oversaw multi-million-dollar projects and played a pivotal role in developing and maintaining relationships in the Life Science and Healthcare sectors. He has also served as the Director of Business Operations at Cognizant, signifying his capability in overseeing essential operational strategies that align with financial and strategic objectives.
In a notable earlier position, he worked as a Senior Manager in Business Development at Cognizant. His contributions here were crucial in leading business development efforts, which resulted in successful client acquisitions and significant revenue growth. Additionally, his foundational experience as a Database Administrator at Oracle provided him with critical insights into data management, infrastructure, and software solutions, which have enriched his later roles in business and operations management.
Achievements
Some of Kaustuva’s key achievements include leading the business development and marketing team for the Asia Pacific region, where he effectively planned and executed strategies that resulted in the establishment of new regions including New Zealand and the expansion of development centers in China. His expertise in operations is showcased through his role as Operations Director for Australia and New Zealand. Here, he played a key role in setting up essential processes including HR, finance, legal, and administrative functions for new regions, underscoring his capability in streamlined business operations.
In addition to setting up new operational frameworks, he has successfully led acquisition analysis and integration efforts, further proving his strategic planning and analytical capabilities. His strong focus on financial planning and reporting has helped various organizations better align their business strategies with financial performance, demonstrating his integral role in successful corporate strategy execution.
Highlights
Jennifer Doudna — #CRISPR pioneer, Nobel laureate, and founder of the Innovative Genomics Institute — is one of Fast Company's 10 Most Innovative People of the Last 10 Years.
The only scientist on the list, she is recognized alongside fellow luminaries of their fields: Jose Andres (World Central Kitchen), Lina Khan (Federal Trade Commission), Pat McGrath (PAT McGRATH LABS), Lin-Manuel Miranda, Satya Nadella (Microsoft), Sara Nelson (Association of Flight Attendants-CWA), Issa Rae (HOORAE), Ryan Reynolds (Maximum Effort, MNTN), and Ted Sarandos (Netflix).
Our thanks to editor-in-chief Brendan Vaughan and the Fast Company team for spotlighting Dr. Doudna as part of this extraordinary group whose ongoing breakthrough contributions are transforming our society.
Check out the announcement page to learn more, keep an eye out for 10 special FC magazine covers (the photos are amazing!), and mark your calendars for the publication's Innovation Festival featuring interviews with each innovator this September 16-19 in New York: https://lnkd.in/gayW8AWk
#FCFestival
The world now has its first approved #CRISPR-based therapy. Let that sink in.
To go from paper to patients in little over a decade is remarkable. Moving forward, the lives of traditionally underserved patients suffering from #sicklecelldisease and beta thalassemia will be forever changed because of Casgevy - a breakthrough treatment that offers a new standard of care.
It's a historic, celebratory milestone that officially marks the start of the era of CRISPR medicine.
The statement below from our client Dr. Jennifer Doudna - Nobel Laureate, co-inventor of CRISPR technology, and the founder of the Innovative Genomics Institute - conveys the elation and emotion that patients and many involved in the field feel.
"I am excited and a bit overwhelmed with emotion at the news of the approval of Casgevy in the UK. Going from the lab to an approved therapy in just 11 years is a truly remarkable achievement. I am especially pleased that the first CRISPR therapy helps patients with sickle cell disease, a disease that has long been neglected by the medical establishment. This is a win for medicine and for health equity. Today is an extraordinary moment for the field, for patients in need, and for the future."
At Thermal, we share that sense of awe. We have been assisting the innovators making this future a reality for a decade, and we are committed to supporting their work and the long-term reputation and impact of this most profound technology.
Congratulations to CRISPR Therapeutics, Vertex Pharmaceuticals, and the many researchers, doctors, and patients. Today was indeed a landmark moment for science and medicine - and it's just the start.
Here's a link to the press release: https://lnkd.in/geQ_qy6y
